Systemic antifungal agents used to treat onychomycosis (Q44032641)

29 November 2017

1 reference

title

Systemic antifungal agents used to treat onychomycosis (English)

1 reference

29 November 2017

Katz HI

1

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Journal of the American Academy of Dermatology

29 November 2017

published in

1 reference

29 November 2017

volume

38

1 reference

29 November 2017

issue

5 Pt 3

1 reference

29 November 2017

page(s)

S48-52

1 reference

Recent advances: the cytochrome P450 enzymes.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Clinical importance of hepatic cytochrome P450 in drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

In vivo interaction of ketoconazole and sucralfate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Interactions and Toxicities of Drugs Used in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Pharmacokinetic drug interactions with antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Adverse drug reactions to systemic antifungals. Prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Clinical pearl: systemic antifungal drugs and drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Oral azole drugs as systemic antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Effects of ranitidine and sucralfate on ketoconazole bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Drug interactions with antacids. Mechanisms and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Itraconazole interacts with felodipine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Effect of ketoconazole on hepatic oxidative drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Clinical pharmacokinetics of ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

Probable interaction between fluoxetine and itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970484-0

7 January 2021

10.1016/S0190-9622(98)70484-0

Identifiers

DOI

1 reference

29 November 2017

1 reference